Y-MABS THERAPEUTICS INC (YMAB) Stock Analyst Earnings Estimates
NASDAQ:YMAB - Nasdaq - US9842411095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 65.27M 87.02% | 84.819M 29.95% | 87.685M 3.38% | 84.062M -4.13% | 96.867M 15.23% | 109.8M 13.35% | 134.8M 22.77% | 205.43M 52.40% | 302.19M 47.10% | 264.44M -12.49% | 392.63M 48.48% | |
| EBITDA YoY % growth | -93.97M 18.04% | -20.455M 78.23% | -29.143M -42.47% | -48.202M -65.40% | -45.944M 4.68% | -46.821M -1.91% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -94.81M 17.86% | -21.19M 77.65% | -29.678M -40.06% | -46.942M -58.17% | -57.856M -23.25% | -65.37M -12.99% | -57.618M 11.86% | -16.276M 71.75% | 50.463M 410.05% | 12.324M -75.58% | 87.674M 611.41% | |
| Operating Margin | -145.26% | -24.98% | -33.85% | -55.84% | -59.73% | -59.54% | -42.74% | -7.92% | 16.70% | 4.66% | 22.33% | |
| EPS YoY % growth | -2.18 19.85% | -0.49 77.52% | -0.67 -36.73% | -1.01 -50.11% | -1.10 -9.20% | -1.09 0.49% | -0.79 28.13% | -0.27 65.19% | 0.50 282.84% | 0.45 -9.53% | 1.23 171.44% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.24 -49.46% | -0.31 -109.29% | -0.32 -166.90% |
| Revenue Q2Q % growth | 21.439M 16.13% | 22.973M -13.29% | 21.273M 1.77% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.178M -30.46% | -12.897M -192.24% | -17.106M -161.45% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.07 66.67% | -0.27 | 0.20 | 74.16% |
| Q1 2025 Q2Q % growth | -0.12 20.00% | -0.22 | 0.10 | 44.37% |
| Q4 2024 Q2Q % growth | -0.15 -650.00% | -0.13 | -0.02 | -18.84% |
| Q3 2024 Q2Q % growth | -0.16 11.11% | -0.16 | 0.00 | 0.40% |
| Q2 2024 Q2Q % growth | -0.21 -50.00% | -0.13 | -0.08 | -56.65% |
| Q1 2024 Q2Q % growth | -0.15 | -0.14 | -0.01 | -8.29% |
| Q4 2023 Q2Q % growth | -0.02 -166.67% | -0.21 | 0.19 | 90.24% |
| Q3 2023 Q2Q % growth | -0.18 71.43% | -0.19 | 0.01 | 5.56% |
| Q2 2023 Q2Q % growth | -0.14 85.11% | -0.25 | 0.11 | 43.21% |
| Q1 2023 Q2Q % growth | -0.15 76.56% | -0.32 | 0.17 | 53.84% |
| Q4 2022 Q2Q % growth | 0.03 103.53% | -0.47 | 0.50 | 106.45% |
| Q3 2022 Q2Q % growth | -0.63 4.55% | -0.72 | 0.09 | 13.01% |
| Q2 2022 Q2Q % growth | -0.94 -77.36% | -0.68 | -0.26 | -38.47% |
| Q1 2022 Q2Q % growth | -0.64 5.88% | -0.73 | 0.09 | 12.45% |
| Q4 2021 Q2Q % growth | -0.85 -77.08% | -0.72 | -0.13 | -18.32% |
| Q3 2021 Q2Q % growth | -0.66 19.51% | -0.61 | -0.05 | -8.20% |
| Q2 2021 Q2Q % growth | -0.53 47.52% | -0.68 | 0.15 | 21.98% |
| Q1 2021 Q2Q % growth | -0.68 -3.03% | 0.19 | -0.87 | -450.88% |
| Q4 2020 Q2Q % growth | -0.48 20.00% | -0.52 | 0.04 | 7.12% |
| Q3 2020 Q2Q % growth | -0.82 -17.14% | -0.80 | -0.02 | -2.41% |
| Q2 2020 Q2Q % growth | -1.01 -90.57% | -0.69 | -0.32 | -46.57% |
| Q1 2020 Q2Q % growth | -0.66 -40.43% | -0.64 | -0.02 | -3.81% |
| Q4 2019 Q2Q % growth | -0.60 | -0.68 | 0.08 | 12.02% |
| Q3 2019 Q2Q % growth | -0.70 | -0.56 | -0.14 | -24.40% |
| Q2 2019 Q2Q % growth | -0.53 | -0.50 | -0.03 | -6.92% |
| Q1 2019 Q2Q % growth | -0.47 | -0.41 | -0.06 | -13.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 19.525M -14.36% | 18.762M | 763K | 4.07% |
| Q1 2025 Q2Q % growth | 20.904M 4.88% | 19.997M | 907K | 4.54% |
| Q4 2024 Q2Q % growth | 26.495M 13.41% | 27.835M | -1.34M | -4.81% |
| Q3 2024 Q2Q % growth | 18.461M -9.74% | 23.728M | -5.267M | -22.20% |
| Q2 2024 Q2Q % growth | 22.798M 9.86% | 23.479M | -681K | -2.90% |
| Q1 2024 Q2Q % growth | 19.931M -1.58% | 22.664M | -2.733M | -12.06% |
| Q4 2023 Q2Q % growth | 23.363M -25.71% | 21.374M | 1.989M | 9.31% |
| Q3 2023 Q2Q % growth | 20.454M 63.11% | 21.348M | -894K | -4.19% |
| Q2 2023 Q2Q % growth | 20.751M 92.14% | 20.176M | 575K | 2.85% |
| Q1 2023 Q2Q % growth | 20.251M 93.05% | 15.864M | 4.387M | 27.65% |
| Q4 2022 Q2Q % growth | 31.45M 227.60% | 20.464M | 10.986M | 53.68% |
| Q3 2022 Q2Q % growth | 12.54M 39.80% | 12.248M | 292K | 2.38% |
| Q2 2022 Q2Q % growth | 10.8M -1.37% | 11.441M | -641K | -5.60% |
| Q1 2022 Q2Q % growth | 10.49M 94.98% | 11.119M | -629K | -5.66% |
| Q4 2021 Q2Q % growth | 9.6M -53.73% | 11.037M | -1.437M | -13.02% |
| Q3 2021 Q2Q % growth | 8.97M | 11.092M | -2.122M | -19.13% |
| Q2 2021 Q2Q % growth | 10.95M | 7.474M | 3.476M | 46.51% |
| Q1 2021 Q2Q % growth | 5.38M | 45.359M | -39.979M | -88.14% |
| Q4 2020 Q2Q % growth | 20.75M | 15.854M | 4.896M | 30.88% |
| Q1 2020 Q2Q % growth | 45.329K | -45.329K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.42% | 0% | 5.01% |
| Revenue | 0% | -2.64% | 0% | 0.03% |